论文部分内容阅读
美喘清是一种新型的选择性β_2受体兴奋剂,除有明显的支气管扩张作用外,还有较强的抗过敏及镇咳,去痰作用。1997年11月至1998年5月我们应用美喘清治疗小儿咳嗽变异性哮喘30例,取得了较好的疗效,现报告如下。 资料与方法 1 对象和分组 全部病例均为我科呼吸专科门诊病例,诊断符合1993年全国儿科哮喘协作组所制定的诊断标准。55例中男33例,女22例,其中10月至3岁16例,3至6岁21例,大于6岁18例。咳嗽时间最短1月,最长达1年,平均
MeiChuanQing is a new type of selective β_2 receptor agonist, in addition to obvious bronchodilator effect, but also strong anti-allergic and antitussive, expectorant effect. From November 1997 to May 1998, we applied Mechuanqing to treat 30 cases of pediatric cough variant asthma and achieved good curative effect. The report is as follows. Materials and Methods 1 Subjects and subgroups All cases were outpatient respiratory specialist cases, the diagnosis consistent with the 1993 National Pediatric Asthma Collaboration developed by the diagnostic criteria. There were 33 males and 22 females in 55 cases, of whom 16 cases were from October to 3 years old, 21 cases were from 3 to 6 years old and 18 cases were older than 6 years old. Coughing the shortest January, up to 1 year, on average